GGrantIndex
← Leaderboards

Mirjana Maletic-Savatic

State University New York Stony Brook

$7,420,032
Attributed
$11,390,168
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,390,168 · 9

By mechanism

R01$7,940,272 · 3
P50$2,183,659 · 2
K08$873,530 · 1
R21$378,569 · 1
M01$14,138 · 2

Top collaborators

Most similar at State University New York Stony Brook

Same institution · by research overlap

Others in their field

Top investigators on “Machine Learning

Research focus

Machine LearningBiological MarkersCellsMetabolomicsMetabolomeBrainPhenotypeAlgorithmsMass Spectrum AnalysisBiologicalMolecularResponseSignal TransductionNeuronsComplementBloodInnovationInterestData AnalysesData SetSensitivity And SpecificityLearningBaseTissues

Grant awards (31)

Clinical trial readiness biomarkers for gene dosage-dependent disorders$1,180,690
P50 · FY2025 · HD · contact PI
Using MR Spectroscopy to Measure Mammalian Neurogenesis in Vivo$719,820
R01 · FY2025 · AG · contact PI
Effects of 16p11.2 copy number variation on neuronal development and pathology$699,666
R01 · FY2025 · MH
Effects of 16p11.2 copy number variation on neuronal development and pathology$832,810
R01 · FY2024 · MH
Using MR Spectroscopy to Measure Mammalian Neurogenesis in Vivo$759,246
R01 · FY2024 · AG · contact PI
Clinical trial readiness biomarkers for gene dosage-dependent disorders$200,625
P50 · FY2024 · HD · contact PI
Effects of 16p11.2 copy number variation on neuronal development and pathology$861,572
R01 · FY2023 · MH
Using MR Spectroscopy to Measure Mammalian Neurogenesis in Vivo$772,901
R01 · FY2023 · AG · contact PI
Clinical trial readiness biomarkers for gene dosage-dependent disorders$200,625
P50 · FY2023 · HD · contact PI
Using MR Spectroscopy to Measure Mammalian Neurogenesis in Vivo$790,556
R01 · FY2022 · AG · contact PI
Clinical trial readiness biomarkers for gene dosage-dependent disorders$200,625
P50 · FY2022 · HD · contact PI
Advanced Computational Approaches for NMR Data-mining$356,625
R01 · FY2021 · GM · contact PI
Advanced Computational Approaches for NMR Data-mining$267,499
R01 · FY2021 · GM · contact PI
Clinical trial readiness biomarkers for gene dosage-dependent disorders$200,625
P50 · FY2021 · HD · contact PI
Biomarker discovery of Alzheimer's disease trajectory using NMR platform$10,805
R01 · FY2021 · GM · contact PI
Advanced Computational Approaches for NMR Data-mining$356,625
R01 · FY2020 · GM · contact PI
Imaging Mass Spectrometry for metabolome mapping$209,619
R01 · FY2020 · GM · contact PI
Clinical trial readiness biomarkers for gene dosage-dependent disorders$200,469
P50 · FY2020 · HD · contact PI
Advanced Computational Approaches for NMR Data-mining$356,625
R01 · FY2019 · GM · contact PI
Advanced Computational Approaches for NMR Data-mining$356,625
R01 · FY2018 · GM · contact PI
5R01GM120033-02 Advanced Computational Approaches for NMR Data-mining Supplement Proposal$232,653
R01 · FY2018 · GM · contact PI
Advanced Computational Approaches for NMR Data-mining$356,625
R01 · FY2017 · GM · contact PI
Identification and tracking of neural stem cells in vivo: a metabolomic approach$169,319
R21 · FY2007 · NS · contact PI
CEREBRAL LANGUAGE ORGANIZATION IN CHILDREN WITH AUTISM SPECTRUM DISORDERS$1,426
M01 · FY2007 · RR · contact PI
Identification and tracking of neural stem cells in vivo: a metabolomic approach$209,250
R21 · FY2006 · NS · contact PI
Activity-dependent control: neural progenitor cell fate$174,706
K08 · FY2006 · NS · contact PI
CEREBRAL LANGUAGE ORGANIZATION IN CHILDREN WITH AUTISM SPECTRUM DISORDERS$12,712
M01 · FY2006 · RR · contact PI
Activity-dependent control: neural progenitor cell fate$174,706
K08 · FY2005 · NS
Activity-dependent control: neural progenitor cell fate$174,706
K08 · FY2004 · NS
Activity-dependent control: neural progenitor cell fate$174,706
K08 · FY2003 · NS
Activity-dependent control: neural progenitor cell fate$174,706
K08 · FY2002 · NS